http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
지현준(Hyun Jun Jee),정화경(Hwa Kyung Jung),조수용(Soo Yong Chough),박용균(Yong Kyun Park),서호석(Ho Suk Saw),오민정(Min Jeong Oh),허준용(Jun Young Hur) 대한산부인과학회 2002 Obstetrics & Gynecology Science Vol.45 No.10
Objective : This study was designed to evaluate the patterns of menstruation including menorrhagia using menstrual index, to find out correlations between patient`s own judgement and actual patterns of menstruation in Korean women, and to develop the menstrual diary using menstrual index as a screening of menstrual disorders. Methods : Seventy-seven women teachers of elementary school undergoing routine health screening test were asked to complete a pictorial blood loss assessment chart and a set of interview sheets regarding menstrual history and their subjective judgement on their amount of menstruation. Spearman correlation test was used to assess the correlation between menstrual index which was obtained from pictorial chart and serum hemoglobin concentration. Results : The mean menstrual intervals were 29.8 days (SD±5.1), the mean menstrual duration was 5.6 days (SD±1.3), the mean value of menstrual index was 170.3 (SD±89.2) which varied from 12 to 411, the mean serum hemoglobin concentration was 12.3 g/dL. Significant correlation was found between the serum hemoglobin concentration and the menstrual index (r=-0.29, p=0.01). Seventeen of 20 women who had anemia (serum hemoglobin concentration below 12.0 g/dL) and 25 of 26 women who had menorrhagia (menstrual index above 200) considered her menstruation as `normal`. Conclusion : Many women who have anemia due to menorrhagia are not aware of the serious consequences of menorrhagia. Writing a ‘menstrual diary` using menstrual index would be easier and more practical method in predicting menorrhagia.
지현준(Hyun Jun Jee),정화경(Hwa Kyung Jung),조수용(Soo Yong Chough),박용균(Yong Kyun Park),서호석(Ho Suk Saw),오민정(Min Jeong Oh),허준용(Jun Young Hur) 대한산부인과학회 2002 Obstetrics & Gynecology Science Vol.45 No.10
Clear cell carcinoma of the endometrium is a relatively rare malignancy that is considered to be one of the most aggressive types of endometrial carcinoma. It is an infrequent variant sharing a common Mullerian origin, accounting for 1 to 5 percent of all endometrial cancers. Histologically, these tumors consists of hobnail cells which have translucent or slightly eosinophilic cytoplasm and protrude to lumen of gland. These tumors occur predominantly in postmenopausal women and carry a relatively unfavorable prognosis comparing with other histologic types of endometrial cancer. We experienced a case of clear cell carcinoma of endometrium in a 81-year old women and this case is presented with a brief review of the literaturs.
부인과 악성종양 환자에서 복합 항암화학요법에 따른 세포독성에 대한 Amifostine 의 임상효과에 관한 연구
이린화(Lynn Hwa Lee),지현준(Hyun Jun Jee),정화경(Hwa Kyung Jung),정유아(Yu A Jung),신정호(Jung Ho Shin),오희숙(Hee Suk Oh),박용균(Yong Kyun Park),허준용(Jun Young Hur),조수용(Soo Yong Chough),서호석(Ho Suk Saw) 대한산부인과학회 2001 Obstetrics & Gynecology Science Vol.44 No.11
Objective : Amifostine (Ethyol(R)), an organic thiophosphate, has shown the ability to protect normal, but not neoplastic, tissues from the damaging effects of chemotherapy and radiotherapy in various kinds of cancers. This study was designed to determine ifostine could reduce the serious hematologic and nephrologic toxicities associated with cisplatin based combination chemotherapy in gynecologic cancer patients. Patients and Methods : Forty patients who received cisplatin-based combination chemotherapy were randomized into two groups. They received chemotherapy with or without pretreatment of amifostine before each course. The occurrence of hematologic and renal toxicities were evaluated. Stastical analysis was done by independent t-test and Chi-square test. Results : Hematologic toxicity was evaluated with nadir count of neutrophil and platelet. The nadir count of neutrophil was 2034.2±1199.20/μl in group with pretreatment using amifostine vs 1070.85±472.66/μl in control group (p<0.01). Platelet count was not statistically different. (p<0.16) Grade 3 neutropenia was observed in nine (45%) patients in pretreatment group vs four (20%) patients with control group (p<0.09). Grade 4 neutropenia occurred in one patient only in control group. Renal toxicity was evaluated by serum creatinine and creatinine clearance. Protracted serum creatinine elevation was not significant in both groups. (p<0.14) Reduction of creatinine clearance was less in patients with pretreatment (p<0.01). There were no significant side reactions in subjects using amifostine. Conclusion : Pretreatment with amifostine reduces the neutropenia and nephrotoxicity associated with cisplatin-based combination chemotherapy with gynecologic cancer patients.
양막 및 탈락막 유래 중간엽 줄기세포의 분리 및 특성 규명
윤영선 ( Young Sun Yoon ),정현철 ( Hyun Chul Jeong ),황종하 ( Jong Ha Hwang ),지현준 ( Hyun Jun Jee ),석예선 ( Oye Sun Seok ),조정윤 ( Jung Youn Jo ),김윤정 ( Yun Joung Kim ),이재관 ( Jae Kwan Lee ) 대한산부인과학회 2008 Obstetrics & Gynecology Science Vol.51 No.11
Objectives: The purpose of this study is to isolate a population of multipotent cells from human amnion and decidua, respectively. Methods: Human placentas (gestational age, 30~42 weeks) were obtained after vaginal or cesarean deliveries. Amnions and deciduas were divided mechanically. The collected cells from the amnion and decidua were cultured. Cultured cells were immunophenotypically characterized. The adipogenic, osteogenic and neurogenic differentiation capacities were tested, and their growth kinetics were analyzed. Results: We successfully isolated MSCs from both the amnion and decidua. The phenotype of MSCs cultured from different fetal and maternal parts of the placenta was comparable. The growth kinetics of MSCs derived from amnions and deciduas were similar. Isolated MSCs were differentiated into various cell lines such as adipogenic, osteogenic, myogenic and neurogenic cells. Conclusions: The human amnion and decidua could be an excellent source of MSC because they are easily obtainable after delivery and showed a higher expansion capacity than that of MSCs from adult bone marrow.